Severe Acute Cellular Rejection With High-Grade Lymphocytic Bronchiolitis Following Transition from Tacrolimus to Belatacept in a Lung Transplantation Recipient: A Case Report-Reference-Cited by-同舟云学术

Severe Acute Cellular Rejection With High-Grade Lymphocytic Bronchiolitis Following Transition from Tacrolimus to Belatacept in a Lung Transplantation Recipient: A Case Report

Published:2022-01 Issue:1 Volume:54 Page:165-168
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Nachiappan Arun,Fallah Tara^ORCID,Willert Rebecca^ORCID,Chojnowski Donna^ORCID,Deshpande Charuhas,Courtwright Andrew^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference11 articles.

1. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study);Vincenti;Am J Transplant,2010

2. Belatacept treatment for two yr after liver transplantation is not associated with operational tolerance;Schwarz;Clin Transplant,2015

3. Maintenance belatacept-based immunosuppression in lung transplantation recipients who failed calcineurin inhibitors;Iasella;Transplantation,2018

4. Belatacept for renal rescue in lung transplant patients;Timofte;Transpl Int,2016

5. Imaging evaluation of lung transplantation patients;Amadi;J Thorac Imag,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection;Immunology Letters;2024-06

2. Calcineurin-inhibitor free immunosuppression after lung transplantation – a single center case-control study in 51 patients converted to Mechanistic Target of Rapamycin (mTOR) inhibitors;PLOS ONE;2023-05-18

3. Immunosuppression in lung transplantation: a narrative review;Current Challenges in Thoracic Surgery;2023-04

4. Conversion to belatacept after lung transplantation: Report of 10 cases;PLOS ONE;2023-03-15

5. A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation;American Journal of Transplantation;2022-07